Showing results (281-290 of 415) with videos related to
Sort By:
Pageof 42
Neurourology and Urodynamics|May 29, 2018
Relaxin-2 therapy reverses radiation-induced fibrosis and restores bladder function in miceYouko Ikeda, Irina V Zabbarova, Lori A Birder, et al.Antiviral Research|August 18, 2012
A screen for modulators of large T antigen's ATPase activity uncovers novel inhibitors of Simian Virus 40 and BK virus replicationSandlin P Seguin, Alex W Ireland, Tushar Gupta, et al.Journal of Molecular and Cellular Cardiology|December 3, 2014
Mitochondria-targeted ROS scavenger improves post-ischemic recovery of cardiac function and attenuates mitochondrial abnormalities in aged ratsNelson Escobales, Rebeca E Nuñez, Sehwan Jang, et al.Molecular Pharmacology|August 24, 2017
N-Acetyl-l-Cysteine Protects Astrocytes against Proteotoxicity without Recourse to GlutathioneAmanda M Gleixner, Daniel F Hutchison, Sara Sannino, et al.Journal of Cell Science|August 23, 2018
Compensatory increases of select proteostasis networks after Hsp70 inhibition in cancer cellsSara Sannino, Christopher J Guerriero, Amit J Sabnis, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 11, 2018
A chemical genetics approach identifies PTP4A3 as a regulator of colon cancer cell adhesionKelley E McQueeney, Joseph M Salamoun, Jennifer G Ahn, et al.Analytical Biochemistry|November 10, 2024
Assays to measure small molecule Hsp70 agonist activity in vitro and in vivoOlivia Shapiro, Clara Woods, Amanda M Gleixner, et al.Human Molecular Genetics|November 17, 2018
Mitochondrial energetics is impaired in very long-chain acyl-CoA dehydrogenase deficiency and can be rescued by treatment with mitochondria-targeted electron scavengersBianca Seminotti, Guilhian Leipnitz, Anuradha Karunanidhi, et al.Anticancer Research|November 1, 2007
Pharmacology and antitumor activity of a quinolinedione Cdc25 phosphatase inhibitor DA3003-1 (NSC 663284)Jianxia Guo, Robert A Parise, Erin Joseph, et al.Annals of Surgery|January 25, 2007
Treatment with a novel hemigramicidin-TEMPO conjugate prolongs survival in a rat model of lethal hemorrhagic shockCarlos A Macias, Jeffrey W Chiao, Jingbo Xiao, et al.Pageof 42